Posted in | News | Laser | Fibre Optics

IMRA and TRUMPF Enter Fiber Laser Business Partnership

IMRA America, Inc., (IMRA) world leader in the research, development, manufacturing and application of ultrafast fiber lasers and TRUMPF GmbH + Co. KG (TRUMPF), a leading global technology company with machine tools, laser technology, electronics and medical technology as its business fields, have announced their partnership.

TRUMPF and IMRA will utilize their combined capabilities to push the industrial application of fiber lasers in the picosecond regime.

Within this partnership, IMRA licenses TRUMPF to use the relevant patents to manufacture fiber lasers within the picosecond field of use. In addition, IMRA and TRUMPF will develop a mutual business relationship with this opportunity.

"I am truly proud to be able to open this important application area for our customers' benefit. We will have another robust and compact tool for the cold processing of materials. We are already very successful in the area of disk-based picosecond lasers and our technology just recently won the German Future Prize," said Peter Leibinger, Vice Chairman of the TRUMPF GmbH + Co. KG and President of the Laser Technology and Electronics Division. "We look forward to building a long association with the IMRA team."

Takashi Omitsu, President of IMRA, commenting on the agreement, said: "IMRA is delighted that we can work with TRUMPF in this important application area. We believe our intellectual property and technical strengths will aid IMRA and TRUMPF together in building a successful business in the industrial fiber-based picosecond laser market."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.